查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2065167

女性科技與女性數位健康市場預測至2034年－全球產品類型、年齡層、通路、部署模式、應用、最終用戶與地區分析

FemTech and Women's Digital Health Market Forecasts to 2034 - Global Analysis By Product Type, Age Group, Distribution Channel, Deployment Mode, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球女性科技和女性數位健康市場預計將在 2026 年達到 71 億美元，到 2034 年達到 268 億美元，在預測期內以 18.1% 的複合年成長率成長。

女性科技和女性數位健康指的是一個快速發展的領域，涵蓋以科技驅動的產品和服務，旨在滿足女性在整個生命週期中的健康需求。這個市場包括行動應用程式、穿戴式裝置、診斷工具、數位療法、基於人工智慧的健康平台以及遠端醫療服務，其關注的疾病包括月經健康、不孕症、懷孕、更年期、骨盆底健康、性健康和心理健康。

人們對性別健康差異的認知不斷提高，女性參與數位健康的比例也不斷增加。

人們日益意識到女性在臨床研究中系統性代表性不足以及已證實的健康結果存在差異，這推動了對性別專屬數位健康解決方案的需求。女性更容易受到一些歷來研究經費有限的疾病的影響，例如子宮卵巢異位症、多囊性卵巢症候群和自體免疫疾病。女性健康科技平台提供檢驗的健康資訊、社區支持和臨床協調工具，以彌合這些差距。智慧型手機普及率的提高、女性投資者對健康科技領域參與度的增加以及雇主不斷擴大的健康計劃，正在加速不同人口統計和地理群體對女性健康科技平台的採用。

關於女性健康科技產品的監管模糊性和缺乏臨床證據標準

許多女性健康科技應用和設備被宣傳為健康工具而非醫療設備，這使得它們處於監管灰色地帶，並限制了市場准入所需的臨床證據的嚴謹性。這種模糊性削弱了臨床醫生的信心，降低了其被納入正規醫療流程的可能性，並使消費者面臨未經檢驗的產品風險。自然週期追蹤應用程式因其避孕效果的宣傳而受到監管機構的審查，凸顯了監管重新分類的風險。建立清晰的臨床檢驗標準、數位生物標記認證框架以及透明的資料隱私保護措施，對於維護市場信譽至關重要。

雇主為女性提供的健康福利不斷擴大，這正在創造 B2B 分銷管道。

企業健康計畫正日益融入與女性科技相關的福利，以吸引和留住女性人才，包括不孕症治療、更年期支持、心理健康服務以及產前產後護理調整等。與女性科技平台合作的雇主可以獲得人口層面的健康數據，以便更好地設計健康計畫；而員工則可以享受個人化健康服務的補貼。這種B2B分銷模式為女性科技公司提供了除直接面對消費者銷售之外的可擴展收入來源，從而降低了獲客成本並提高了客戶維繫。不斷擴大的雇主保險要求以及大型企業為解決健康差異所做的自願努力，進一步增加了這一管道的機會。

生殖健康資料的資料安全漏洞和隱私問題

女性健康科技應用極易成為資料外洩和濫用的目標，因為它們會收集高度敏感的個人健康數據，包括月經週期、生育狀況、懷孕進度和性行為。多個司法管轄區的生殖權利立法引發了人們的擔憂，即月經週期和生育數據可能被傳喚或出售給第三方，導致用戶強烈抵制和應用卸載。一些女性健康科技供應商採用的加密標準不足且資料貨幣化方式不透明，加劇了隱私風險，可能阻礙注重隱私的消費者使用，並給在多個司法管轄區運營的公司帶來監管風險。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了女性健康科技（femtech）的普及，因為疫情封鎖期間，婦產科和生育診所的離線就診受到嚴重限制。隨著患者尋求遠距就診以外的替代方案，專注於女性健康的遠端保健平台使用者數量顯著成長。疫情期間，人們健康意識的提高和數位化應用的普及，使得許多女性首次接觸到女性健康科技解決方案。疫情後，遠端保健的持續使用、人們對遠距健康監測的日益熟悉，以及創業投資成長，正在推動各個細分市場的擴張。

在預測期內，行動應用領域預計將成為規模最大的領域。

行動應用是女性科技和女性數位健康市場中最大的產品類別，這體現了基於智慧型手機的健康工具的易用性、低成本部署潛力和廣泛的功能。涵蓋月經週期追蹤、生育監測、懷孕指導和心理健康等方面的應用已吸引了全球數億註冊用戶。領先平台採用的免費增值經營模式有助於大規模總合獲取，而付費訂閱則能帶來永續的收入來源。機器學習驅動的個人化功能以及與穿戴式裝置的整合正在提升行動女性科技應用的使用者參與度和臨床效用。

預計在預測期內，面向女性的人工智慧醫療保健平台細分市場將實現最高的複合年成長率。

預計在預測期內，面向女性的AI健康平台將實現最高的複合年成長率，這得益於它們能夠整合多模態健康數據，包括激素生物標記、穿戴式感測器數據和自我報告的症狀信息，從而提供個性化的臨床見解。這些平台正從被動的數據聚合轉向主動的健康管理，產生預測性警報、個人化的治療建議以及便於醫療專業人員使用的健康摘要。 AI平台的收入來源也正在多元化，不再局限於直接面對消費者的訂閱，還包括與製藥公司合作招募臨床試驗參與者，以及與健康保險公司合作進行人群健康管理計畫。

市佔率最大的地區：

預計北美將在整個預測期內佔據最大的市場佔有率。北美在全球女性科技和女性數位健康市場中處於領先地位，這得益於其充滿活力的創業投資系統、智慧型手機的高普及率、支持遠端保健的法規結構以及對健康科技創新持開放態度的消費者群體。美國擁有大多數全球知名的女性科技公司，並佔據最大的投資和收入佔有率。雇主提供的女性健康福利計劃的擴展、醫療保健專業人員意識的提高以及先進健康數據基礎設施的發展，預計將使北美在整個預測期內保持其市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。智慧型手機網路普及率的快速成長、龐大且服務不足的女性群體以及中產階級對個人健康照護投入的增加，共同推動了亞太地區在女性健康科技市場實現最高的複合年成長率。在中國、印度、日本和韓國等國家，在政府醫療數位化計畫的支持下，女性數位健康領域的投資活動日益活躍。此外，隨著社會對女性健康態度的轉變、數位健康工具監管的放鬆以及疫情期間遠端醫療基礎設施的發展，亞太地區已成為女性健康科技市場成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球女性科技與女性數位健康市場：依產品類型分類

  • 行動應用
  • 穿戴式裝置
  • 診斷設備
    • 家用不孕症檢測套組
    • 檢測套組
    • 荷爾蒙監測設備
  • 數位療法
  • 遠端醫療平台
  • 女性導向的AI賦能醫療保健平台

第6章：全球女性科技與女性數位健康市場：依年齡層別分類

  • 青少年
  • 成年人（20-40歲）
  • 中年女性（41-55歲）
  • 老年女性（55歲以上）

第7章：全球女性科技與女性數位健康市場：按分銷管道分類

  • App Store
  • 直接面對消費者 (DTC) 平台
  • 零售藥房
  • 線上藥局和電子商務平台
  • 醫療服務提供方

第8章：全球女性科技與女性數位健康市場：依部署模式分類

  • 基於雲端的
  • 現場
  • 混合實現

第9章：全球女性科技與女性數位健康市場：按應用領域分類

  • 月經健康管理
  • 不孕不育與生殖健康
  • 懷孕和哺乳期護理
  • 骨盆腔和子宮健康
  • 更年期護理
  • 性健康
  • 乳房健康
  • 心理健康與福祉

第10章 全球女性科技與女性數位健康市場：依最終使用者分類

  • 個人消費者
  • 醫院和診所
  • 不孕症治療中心
  • 診斷中心
  • 產科護理中心
  • 研究機構
  • 雇主和企業健康計劃

第11章 全球女性科技與女性數位健康市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Flo Health
  • Natural Cycles
  • Elvie
  • Clue
  • Maven Clinic
  • Kindbody
  • HeraMED
  • Bloomlife
  • Ava Science
  • Willow Innovations
  • iSono Health
  • Carrot Fertility
  • Nurx
  • Midi Health
  • Progyny
Product Code: SMRC36763

According to Stratistics MRC, the Global FemTech and Women's Digital Health Market is accounted for $7.1 billion in 2026 and is expected to reach $26.8 billion by 2034, growing at a CAGR of 18.1% during the forecast period. FemTech and Women's Digital Health encompasses a rapidly expanding category of technology-enabled products and services designed specifically to address women's health needs across the life cycle. This market includes mobile applications, wearable devices, diagnostic tools, digital therapeutics, AI-based health platforms, and telehealth services targeting conditions such as menstrual health, fertility, pregnancy, menopause, pelvic health, sexual wellness, and mental health.

Market Dynamics:

Driver:

Growing awareness of gender health disparities and increasing female digital health engagement

Heightened awareness of systemic underrepresentation of women in clinical research and documented health outcome disparities is driving demand for gender-specific digital health solutions. Women are disproportionately affected by conditions such as endometriosis, polycystic ovarian syndrome, and autoimmune disorders that historically have received limited research investment. FemTech platforms provide access to validated health information, community support, and clinical coordination tools that address these gaps. Rising smartphone penetration, growing female investor participation in health tech, and expanded employer wellness program coverage are accelerating adoption across diverse demographic and geographic segments.

Restraint:

Regulatory ambiguity and lack of clinical evidence standards for FemTech products

Many FemTech applications and devices occupy a regulatory gray zone, marketed as wellness tools rather than medical devices, limiting the rigor of clinical evidence required for market entry. This ambiguity undermines clinician trust, reduces potential integration into formal healthcare pathways, and exposes consumers to products with unvalidated efficacy claims. Natural cycle tracking applications facing regulatory scrutiny over contraceptive claims highlight the risk of regulatory reclassification. Establishing clear clinical validation standards, digital biomarker certification frameworks, and transparent data privacy practices will be essential for sustainable market credibility.

Opportunity:

Employer-sponsored women's health benefits expansion creating B2B distribution channel

Corporate wellness programs are increasingly incorporating FemTech benefits to attract and retain female talent, addressing fertility coverage, menopause support, mental health services, and maternity care coordination. Employers partnering with FemTech platforms gain access to population-level health data that informs wellness program design while employees receive subsidized access to personalized health services. This B2B distribution model provides FemTech companies with scalable revenue streams beyond direct-to-consumer sales, reducing customer acquisition costs and improving retention. Expansion of employer coverage mandates and voluntary health equity commitments by major corporations is amplifying this channel opportunity.

Threat:

Data security vulnerabilities and reproductive health data privacy concerns

FemTech applications collect highly sensitive personal health data including menstrual cycles, fertility status, pregnancy outcomes, and sexual behavior, making them prime targets for data breaches and misuse. Legislative shifts regarding reproductive rights in several jurisdictions have heightened concerns that period tracking and fertility data could be subpoenaed or sold to third parties, triggering significant user backlash and app uninstallations. Inadequate encryption standards and opaque data monetization practices among some FemTech vendors compound privacy risks, potentially deterring adoption by privacy-conscious consumers and creating regulatory exposure for companies operating across multiple legal jurisdictions.

Covid-19 Impact:

The COVID-19 pandemic accelerated FemTech adoption as access to in-person obstetric, gynecological, and fertility clinic consultations was severely curtailed during lockdown periods. Telehealth platforms specializing in women's health experienced substantial user growth as patients sought remote consultation alternatives. Heightened health awareness and digital engagement during the pandemic introduced many women to FemTech solutions for the first time. Post-pandemic, sustained telehealth utilization, growing comfort with remote health monitoring, and increased venture capital investment in women's health innovation continue to drive market expansion across all segments.

The Mobile Applications segment is expected to be the largest during the forecast period

Mobile applications represent the largest product segment in the FemTech and women's digital health market, reflecting the accessibility, low cost of entry, and broad functional scope of smartphone-based health tools. Applications addressing menstrual health tracking, fertility monitoring, pregnancy guidance, and mental wellness collectively attract hundreds of millions of registered users globally. The freemium business model employed by leading platforms drives mass user acquisition while premium subscription conversion generates recurring revenue streams. Machine learning-powered personalization features and integration with wearable devices are enhancing user engagement and clinical utility of mobile FemTech applications.

The AI-Based Women's Health Platforms segment is expected to have the highest CAGR during the forecast period

AI-based women's health platforms are expected to register the highest CAGR during the forecast period, driven by their capacity to synthesize multimodal health data including hormonal biomarkers, wearable sensor inputs, and self-reported symptom information to deliver individualized clinical insights. These platforms are transitioning from passive data aggregation toward active health management, generating predictive alerts, personalized treatment recommendations, and clinician-ready health summaries. Partnerships with pharmaceutical companies for clinical trial participant recruitment and with health insurers for population health management programs are diversifying AI platform revenue streams beyond direct consumer subscriptions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, North America leads the global FemTech and women's digital health market, benefitting from a vibrant venture capital ecosystem, high smartphone penetration, supportive telehealth regulatory frameworks, and a culturally receptive consumer base for health technology innovation. The United States hosts the majority of globally recognized FemTech companies and accounts for the largest share of investment and revenue. Expanding employer-sponsored women's health benefit programs, growing awareness among healthcare providers, and availability of sophisticated health data infrastructure collectively sustain North America's dominant market position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Asia Pacific is forecast to deliver the highest CAGR in the FemTech market, propelled by rapidly expanding smartphone internet penetration, a large and underserved female population, and growing middle-class investment in personal health management. Countries including China, India, Japan, and South Korea are witnessing increasing venture activity in women's digital health, supported by government health digitization programs. Cultural shifts toward proactive women's health awareness, easing regulatory pathways for digital health tools, and telehealth infrastructure built during the pandemic are collectively driving Asia Pacific's emergence as the fastest-growing regional FemTech market.

Key players in the market

Some of the key players in Global FemTech and Women's Digital Health Market include Flo Health, Natural Cycles, Elvie, Clue, Maven Clinic, Kindbody, HeraMED, Bloomlife, Ava Science, Willow Innovations, iSono Health, Carrot Fertility, Nurx, Midi Health, and Progyny.

Key Developments:

In March 2026, Flo Health announced the launch of an AI-powered menopause health management feature integrated within its core application, incorporating symptom tracking, personalized care recommendations, and telehealth appointment scheduling capabilities, expanding the platform's lifecycle health coverage beyond reproductive years for its global user base.

In February 2026, Maven Clinic secured a major enterprise partnership with a Fortune 500 employer to provide comprehensive virtual women's health and family benefits coverage to over 80,000 employees globally, expanding its employer client base and reinforcing its position as a leading B2B women's digital health platform.

Product Types Covered:

  • Mobile Applications
  • Wearable Devices
  • Diagnostic Devices
  • Digital Therapeutics
  • Telehealth Platforms
  • AI-based Women's Health Platforms

Age Groups Covered:

  • Teenagers
  • Adults (20-40 Years)
  • Middle-aged Women (41-55 Years)
  • Senior Women (Above 55 Years)

Distribution Channels Covered:

  • App Stores
  • Direct-to-Consumer Platforms
  • Retail Pharmacies
  • Online Pharmacies & E-commerce
  • Healthcare Providers

Deployment Modes Covered:

  • Cloud-based
  • On-premises
  • Hybrid Deployment

Applications Covered:

  • Menstrual Health
  • Fertility & Reproductive Health
  • Pregnancy & Nursing Care
  • Pelvic & Uterine Health
  • Menopause Care
  • Sexual Wellness
  • Breast Health
  • Mental Health & Wellness

End Users Covered:

  • Individual Consumers
  • Hospitals & Clinics
  • Fertility Centers
  • Diagnostic Centers
  • Maternity Care Centers
  • Research Institutes
  • Employers & Corporate Wellness Programs

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global FemTech and Women's Digital Health Market, By Product Type

  • 5.1 Mobile Applications
  • 5.2 Wearable Devices
  • 5.3 Diagnostic Devices
    • 5.3.1 Home Fertility Testing Kits
    • 5.3.2 Pregnancy Test Devices
    • 5.3.3 Hormone Monitoring Devices
  • 5.4 Digital Therapeutics
  • 5.5 Telehealth Platforms
  • 5.6 AI-based Women's Health Platforms

6 Global FemTech and Women's Digital Health Market, By Age Group

  • 6.1 Teenagers
  • 6.2 Adults (20-40 Years)
  • 6.3 Middle-aged Women (41-55 Years)
  • 6.4 Senior Women (Above 55 Years)

7 Global FemTech and Women's Digital Health Market, By Distribution Channel

  • 7.1 App Stores
  • 7.2 Direct-to-Consumer (DTC) Platforms
  • 7.3 Retail Pharmacies
  • 7.4 Online Pharmacies & E-commerce Platforms
  • 7.5 Healthcare Providers

8 Global FemTech and Women's Digital Health Market, By Deployment Mode

  • 8.1 Cloud-based
  • 8.2 On-premises
  • 8.3 Hybrid Deployment

9 Global FemTech and Women's Digital Health Market, By Application

  • 9.1 Menstrual Health Management
  • 9.2 Fertility & Reproductive Health
  • 9.3 Pregnancy & Nursing Care
  • 9.4 Pelvic & Uterine Health
  • 9.5 Menopause Care
  • 9.6 Sexual Wellness
  • 9.7 Breast Health
  • 9.8 Mental Health & Wellness

10 Global FemTech and Women's Digital Health Market, By End User

  • 10.1 Individual Consumers
  • 10.2 Hospitals & Clinics
  • 10.3 Fertility Centers
  • 10.4 Diagnostic Centers
  • 10.5 Maternity Care Centers
  • 10.6 Research Institutes
  • 10.7 Employers & Corporate Wellness Programs

11 Global FemTech and Women's Digital Health Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Flo Health
  • 14.2 Natural Cycles
  • 14.3 Elvie
  • 14.4 Clue
  • 14.5 Maven Clinic
  • 14.6 Kindbody
  • 14.7 HeraMED
  • 14.8 Bloomlife
  • 14.9 Ava Science
  • 14.10 Willow Innovations
  • 14.11 iSono Health
  • 14.12 Carrot Fertility
  • 14.13 Nurx
  • 14.14 Midi Health
  • 14.15 Progyny

List of Tables

  • Table 1 Global FemTech and Women's Digital Health Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global FemTech and Women's Digital Health Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global FemTech and Women's Digital Health Market Outlook, By Mobile Applications (2023-2034) ($MN)
  • Table 4 Global FemTech and Women's Digital Health Market Outlook, By Wearable Devices (2023-2034) ($MN)
  • Table 5 Global FemTech and Women's Digital Health Market Outlook, By Diagnostic Devices (2023-2034) ($MN)
  • Table 6 Global FemTech and Women's Digital Health Market Outlook, By Home Fertility Testing Kits (2023-2034) ($MN)
  • Table 7 Global FemTech and Women's Digital Health Market Outlook, By Pregnancy Test Devices (2023-2034) ($MN)
  • Table 8 Global FemTech and Women's Digital Health Market Outlook, By Hormone Monitoring Devices (2023-2034) ($MN)
  • Table 9 Global FemTech and Women's Digital Health Market Outlook, By Digital Therapeutics (2023-2034) ($MN)
  • Table 10 Global FemTech and Women's Digital Health Market Outlook, By Telehealth Platforms (2023-2034) ($MN)
  • Table 11 Global FemTech and Women's Digital Health Market Outlook, By AI-based Women's Health Platforms (2023-2034) ($MN)
  • Table 12 Global FemTech and Women's Digital Health Market Outlook, By Age Group (2023-2034) ($MN)
  • Table 13 Global FemTech and Women's Digital Health Market Outlook, By Teenagers (2023-2034) ($MN)
  • Table 14 Global FemTech and Women's Digital Health Market Outlook, By Adults (20-40 Years) (2023-2034) ($MN)
  • Table 15 Global FemTech and Women's Digital Health Market Outlook, By Middle-aged Women (41-55 Years) (2023-2034) ($MN)
  • Table 16 Global FemTech and Women's Digital Health Market Outlook, By Senior Women (Above 55 Years) (2023-2034) ($MN)
  • Table 17 Global FemTech and Women's Digital Health Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 18 Global FemTech and Women's Digital Health Market Outlook, By App Stores (2023-2034) ($MN)
  • Table 19 Global FemTech and Women's Digital Health Market Outlook, By Direct-to-Consumer (DTC) Platforms (2023-2034) ($MN)
  • Table 20 Global FemTech and Women's Digital Health Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 21 Global FemTech and Women's Digital Health Market Outlook, By Online Pharmacies & E-commerce Platforms (2023-2034) ($MN)
  • Table 22 Global FemTech and Women's Digital Health Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 23 Global FemTech and Women's Digital Health Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 24 Global FemTech and Women's Digital Health Market Outlook, By Cloud-based (2023-2034) ($MN)
  • Table 25 Global FemTech and Women's Digital Health Market Outlook, By On-premises (2023-2034) ($MN)
  • Table 26 Global FemTech and Women's Digital Health Market Outlook, By Hybrid Deployment (2023-2034) ($MN)
  • Table 27 Global FemTech and Women's Digital Health Market Outlook, By Application (2023-2034) ($MN)
  • Table 28 Global FemTech and Women's Digital Health Market Outlook, By Menstrual Health Management (2023-2034) ($MN)
  • Table 29 Global FemTech and Women's Digital Health Market Outlook, By Fertility & Reproductive Health (2023-2034) ($MN)
  • Table 30 Global FemTech and Women's Digital Health Market Outlook, By Pregnancy & Nursing Care (2023-2034) ($MN)
  • Table 31 Global FemTech and Women's Digital Health Market Outlook, By Pelvic & Uterine Health (2023-2034) ($MN)
  • Table 32 Global FemTech and Women's Digital Health Market Outlook, By Menopause Care (2023-2034) ($MN)
  • Table 33 Global FemTech and Women's Digital Health Market Outlook, By Sexual Wellness (2023-2034) ($MN)
  • Table 34 Global FemTech and Women's Digital Health Market Outlook, By Breast Health (2023-2034) ($MN)
  • Table 35 Global FemTech and Women's Digital Health Market Outlook, By Mental Health & Wellness (2023-2034) ($MN)
  • Table 36 Global FemTech and Women's Digital Health Market Outlook, By End User (2023-2034) ($MN)
  • Table 37 Global FemTech and Women's Digital Health Market Outlook, By Individual Consumers (2023-2034) ($MN)
  • Table 38 Global FemTech and Women's Digital Health Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 39 Global FemTech and Women's Digital Health Market Outlook, By Fertility Centers (2023-2034) ($MN)
  • Table 40 Global FemTech and Women's Digital Health Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 41 Global FemTech and Women's Digital Health Market Outlook, By Maternity Care Centers (2023-2034) ($MN)
  • Table 42 Global FemTech and Women's Digital Health Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 43 Global FemTech and Women's Digital Health Market Outlook, By Employers & Corporate Wellness Programs (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.